A recent article published in the Journal of Chemical Information and Modeling researchers at Southern Methodist University (SMU) have developed SmartCADD, an open-source virtual tool designed to speed up drug discovery.
SmartCADD combines artificial intelligence, quantum mechanics, and computer-assisted drug design (CADD) techniques to screen billions of chemical compounds, significantly shortening the time needed for drug development.In their study, researchers identified promising HIV drug candidates, highlighting the platform’s potential for broader applications in drug research. The tool’s development was made possible through an interdisciplinary collaboration between SMU’s chemistry and computer science departments.
Related Work
In the past, drug discovery was slowed by challenges such as limited computational power and the manual screening of chemical compounds. Traditional methods also struggled to handle today’s vast chemical databases and predict drug behavior in complex biological systems, leading to longer timelines for identifying promising candidates.
SmartCADD in Drug Discovery
SmartCADD is a virtual tool designed to enhance drug discovery by integrating artificial intelligence (AI), quantum mechanics, and Computer Assisted Drug Design (CADD) techniques. The method starts with SmartCADD’s Pipeline Interface, which collects data and runs a series of filters to analyze chemical compounds.
This interface processes vast amounts of information, quickly screening through billions of compounds to identify those that show potential as drug candidates. The AI-driven models allow for rapid, large-scale analysis, addressing the time-consuming nature of traditional drug discovery methods.
The next step involves SmartCADD’s Filter Interface, which tells the system how to apply different filters to the chemical compounds. These filters are key to narrowing down the vast number of candidates by assessing various drug-related properties.
For instance, the filters predict how each compound will behave in the human body and evaluate the structural compatibility between the drug and target proteins. It helps to significantly streamline the drug testing process, ensuring only the most promising compounds advance to the next stages of analysis.
SmartCADD combines 2D and 3D modeling techniques to visualize the drug molecules and understand their interaction with biological targets. These models provide a detailed understanding of the chemical structure, helping researchers optimize the fit between potential drug molecules and the proteins they aim to interact with.
Additionally, SmartCADD uses explainable AI, which means that the AI’s decision-making process is transparent. This helps researchers understand why certain compounds are considered promising and how the predictions were made.
In a recent study, researchers applied SmartCADD to HIV drug discovery by analyzing data from the MoleculeNet library. By screening 800 million compounds, SmartCADD identified 10 million potential candidates, further refined using filters that focused on the properties of approved HIV drugs.
While the study focused on HIV, the researchers emphasized that SmartCADD can be adapted for various other drug discovery projects, making it a versatile and efficient tool for advancing drug research across multiple fields.
Innovative Drug Screening
The researchers showcased SmartCADD’s effectiveness by applying it to HIV drug discovery in three case studies, targeting specific HIV proteins. Using data from the MoleculeNet library, which contains 800 million chemical compounds, SmartCADD quickly screened and identified 10 million potential drug candidates. The platform then refined these results by comparing them to existing HIV drugs, advancing the most promising candidates for further analysis.
SmartCADD’s AI-driven models also provided insights into how these compounds behave in biological systems, predicting their pharmacokinetics and pharmacodynamics—key factors for understanding drug interactions with the human body. This streamlined approach not only accelerated the identification of viable drug candidates but also demonstrated SmartCADD’s adaptability for other therapeutic targets beyond HIV.
The success of SmartCADD highlights its potential to revolutionize drug discovery across multiple fields, including antibiotics and cancer therapies. It offers a promising tool for tackling urgent global health challenges.
Conclusion
To sum up, researchers at SMU created SmartCADD, an open-source tool that integrates artificial intelligence, quantum mechanics, and Computer Assisted Drug Design to expedite drug discovery.
Its application in HIV research showcased its ability to swiftly screen millions of compounds and adapt to various therapeutic targets. The project underscored the significance of interdisciplinary collaboration in advancing impactful research in drug development.
Journal Reference
Ayesh Madushanka, Laird, E., Clark, C., & Elfi Kraka. (2024). SmartCADD: AI-QM Empowered Drug Discovery Platform with Explainability. Journal of Chemical Information and Modeling, 64(17), 6799–6813. DOI: 10.1021/acs.jcim.4c00720, https://pubs.acs.org/doi/full/10.1021/acs.jcim.4c00720
News
AI and Quantum Mechanics Accelerate Drug Discovery
A recent article published in the Journal of Chemical Information and Modeling researchers at Southern Methodist University (SMU) have developed SmartCADD, an open-source virtual tool designed to speed [...]
Targeting ‘undruggable’ diseases: Researchers reveal new levels of detail in targeted protein degradation
Researchers at the University of Dundee have revealed in the greatest detail yet the workings of molecules called protein degraders which can be deployed to combat what have previously been regarded as "undruggable" diseases, [...]
Revolutionizing Virology: AI Discovers Over 160,000 New RNA Viruses
Largest discovery of new virus species sheds light on the hidden virosphere. Artificial intelligence (AI) has been used to reveal details of a diverse and fundamental branch of life living right under our feet and in every [...]
Cardiac Crisis: COVID-19 Doubles Risk of Heart Attacks, Strokes, and Death
Research indicates that COVID-19 survivors face doubled risks of severe cardiac events for years after recovery, especially if hospitalized. People with A, B, or AB blood types are particularly vulnerable, highlighting the need for personalized approaches [...]
AI steps into science limelight with Nobel wins
For long periods of its history, artificial intelligence has lurked in the hinterland of science, often unloved and unfunded—but two Nobel prizes in one week suggest its time in the sunshine has finally arrived. [...]
MIT Scientists Shed New Light on the Critical Brain Connections That Define Consciousness
A new study provides further evidence that consciousness depends on communication between the brain’s sensory and cognitive regions in the cortex. Our brains are constantly making predictions about our surroundings, enabling us to focus [...]
Common Chemicals Found in Shampoo and Plastic Could Be Quietly Disrupting Your Heart’s Rhythm
UC study of Fernald data links environmental phenols to heart toxicities Environmental phenols are present in numerous everyday consumer products, serving as preservatives in packaged foods, parabens in shampoos, and bisphenol A (BPA) in [...]
Revolutionary Brain Tech Offers New Hope for Stroke and Injury Recovery
University of Pittsburgh researchers report that deep brain stimulation (DBS) can effectively enhance motor functions in individuals with arm and hand paralysis due to brain injuries, with promising results from early human and monkey [...]
NIH Scientists Discover Gene Responsible for Rare Eye Disease
Findings supported by the NIH pave the way for the development of genetic testing, clinical trials, and therapies. Researchers at the National Institutes of Health (NIH) and their collaborators have discovered a gene linked to certain [...]
Alzheimer’s Breakthrough: Synthetic THC Pill Proves Effective in Clinical Trial
Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer’s agitation medications. A study conducted by researchers from Johns Hopkins University School of Medicine and Tufts University School of Medicine found that a pill form [...]
The Future of Rare Disease Treatment with Precision Medicine
Understanding rare diseases Rare diseases affect less than 5 people out of 10,000. However, this still amounts to about 7% of the world’s population, with over 10,000 such conditions. Almost all are genetic in [...]
Doctors issue warning for upcoming ‘tripledemic
The term ‘tripledemic’ has hit headlines this week as the NHS begins its Covid and fluvaccine roll-out for vulnerable adults. As the cold weather sets in, many of us have experienced a decline in health, and this may [...]
The FDA approved a gel that can stop bleeding from wounds in seconds
Aug 15 (Reuters) - The U.S. Food and Drug Administration has cleared Cresilon's gel to quickly control bleeding, the privately held company said on Thursday, potentially giving emergency medical technicians and combat medics a [...]
High levels of microplastics found in prostate tumors, possibly linked to take-out food
The presence of microplastics in prostate tumors points to potential health risks, and researchers are calling for urgent studies to explore how take-out food may be driving this exposure. In a recent study published [...]
AI outperforms radiologists in brain tumor diagnosis
As artificial intelligence advances, its uses and capabilities in real-world applications continue to reach new heights that may even surpass human expertise. In the field of radiology, where a correct diagnosis is crucial to ensure [...]
Breakthrough Study Reveals Molecular Clues to Dementia Origins
Work could lead to the discovery of new therapeutic targets. For the first time, researchers have identified “molecular markers” linked to degeneration—detectable changes in cells and their gene-regulating networks—that are common across several types [...]